8-K: Synergy CHC Reports Eighth Consecutive Quarter of Profitability, Appoints Jaime Fickett as CFO

Synergy CHC Corp. announces its Q4 and full-year 2024 financial results, reporting continued profitability and the appointment of Jaime Fickett as permanent CFO.

Summary

• Synergy CHC Corp. reported its financial results for the three and twelve months ended December 31, 2024.
• The company achieved its eighth consecutive quarter of profitability.
• Fourth-quarter revenue was $10.3 million, a decrease of 22% compared to $13.2 million in the same period last year.
• Full-year revenue was $34.8 million, down 19% from $42.8 million in the previous year.
• The decline in revenue was attributed to the rebranding and de-inventorying of FOCUSfactor and a one-time return of a rotational item.
• Fourth-quarter gross margin was 63.3%, compared to 82.3% in the fourth quarter of 2023.
• Full-year gross margin was 67.9%, down from 75.0% in 2023.
• Net income for the fourth quarter was $105.7 thousand, compared to $2.6 million in the prior year.
• Full-year net income was $2.1 million, down from $6.3 million in 2023.
• Adjusted EBITDA for the full year 2024 was $7.4 million compared to $6.1 million in 2023.
• Jaime Fickett was appointed as the permanent Chief Financial Officer.
• The company completed its initial public offering (IPO) in October 2024, offering 1,150,000 shares at $9.00 per share.
• The company reduced outstanding debt by $4.5 million during the fourth quarter.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue and net income decreased, the company achieved its eighth consecutive quarter of profitability, reduced liabilities, and appointed a permanent CFO. The successful IPO is also a positive factor.

Positives

• The company achieved its eighth consecutive quarter of profitability.
• Jaime Fickett has been appointed as the permanent Chief Financial Officer.
• The company completed its IPO in October 2024.
• Adjusted EBITDA increased for the full year to $7.4 million, compared to $6.1 million in the previous year.
• The company reduced its total liabilities by $6.6 million, from $39.5 million to $33.0 million.
• Inventory decreased from $3.7 million to $1.7 million.
• Expanded partnerships with blue-chip retailers including BJs Wholesale Clubs and Publix.

Negatives

• Revenue decreased in both the fourth quarter (22% decrease to $10.3 million) and full year (19% decrease to $34.8 million).
• Gross margin decreased in both the fourth quarter (63.3% vs. 82.3%) and full year (67.9% vs. 75.0%).
• Net income decreased in both the fourth quarter ($105.7 thousand vs. $2.6 million) and full year ($2.1 million vs. $6.3 million).
• Cash used in operating activities for the year was $4.8 million, compared to cash provided by operating activities of $421.7 thousand in the previous year.

Risks

• The company's future performance is subject to risks, uncertainties, and other factors detailed in its registration statement on Form S-1.
• The rebranding of FOCUSfactor impacted revenue and gross margin.
• The company's reliance on key retailers could pose a risk if those partnerships are disrupted.

Future Outlook

The company is focused on returning to top and bottom-line growth in 2025, with initiatives including new product launches and continued expansion of distribution.

Management Comments

• Jack Ross, CEO of Synergy, stated that the company had another full year of profitability, marking its eighth consecutive profitable quarter.
• Jack Ross noted that fourth-quarter results were impacted by retailer de-inventorying from the FOCUSfactor packaging transition, but sequential improvement was seen, and the transition is now complete.
• Jack Ross expressed excitement about the opportunities ahead and confidence in the company's ability to create long-term value for its shareholders.

Industry Context

Synergy CHC operates in the consumer health care and lifestyle products industry, facing competition from other supplement and wellness brands. The company's focus on brain health supplements (FOCUSfactor) and weight management products (Flat Tummy) aligns with growing consumer interest in these areas. The expansion into ready-to-drink products and GLP-1 support products reflects an adaptation to current market trends.

Comparison to Industry Standards

• Comparing Synergy CHC's performance to industry peers requires considering companies with similar product portfolios and market capitalization.
• Companies like The Vitamin Shoppe (VSI) and Herbalife Nutrition (HLF) operate in the broader health and wellness space, but have significantly larger revenue bases.
• Synergy's gross margin of 67.9% for the full year 2024 is within a reasonable range for the consumer health products industry, but lower than some premium brands.
• The decrease in revenue due to rebranding is a common challenge in the industry, and the success of the new branding will be crucial for future growth.
• The company's focus on expanding distribution through partnerships with retailers like BJs Wholesale Club and Publix is a typical strategy for increasing market reach.

Management Changes

Stakeholder Impact

• Shareholders: The financial results may impact shareholder value, with decreased revenue and net income potentially causing concern.
• Employees: The company's continued profitability and growth initiatives could positively impact employee morale and job security.
• Customers: The rebranding of FOCUSfactor and new product launches may affect customer perception and purchasing decisions.
• Suppliers: The company's financial performance could influence its ability to maintain and expand relationships with suppliers.
• Creditors: The reduction in total liabilities is a positive sign for creditors, indicating improved financial stability.

Next Steps

• The company plans to focus on returning to top and bottom-line growth in 2025.
• Synergy will continue to expand its distribution footprint.
• The company will monitor the performance of its new product launches under the Flat Tummy brand.
• Synergy will host a conference call on March 31, 2025, to discuss the financial results.

Key Dates

Keywords

Synergy CHC, Financial Results, Jaime Fickett, Chief Financial Officer, FOCUSfactor, Flat Tummy, IPO, Profitability, Revenue, EBITDA